Search Results - "Yoneyama, Mihoko Sutoh"

Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection by Yoneyama, Tohru, Tobisawa, Yuki, Kaneko, Tomonori, Kaya, Takatoshi, Hatakeyama, Shingo, Mori, Kazuyuki, Sutoh Yoneyama, Mihoko, Okubo, Teppei, Mitsuzuka, Koji, Duivenvoorden, Wilhelmina, Pinthus, Jehonathan H., Hashimoto, Yasuhiro, Ito, Akihiro, Koie, Takuya, Suda, Yoshihiko, Gardiner, Robert A., Ohyama, Chikara

“…To reduce unnecessary prostate biopsies (Pbx), better discrimination is needed. To identify clinically significant prostate cancer (CSPC) we determined the…”
Get full text

Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy by Yoneyama, Tohru, Hatakeyama, Shingo, Sutoh-Yoneyama, Mihoko, Yoshiya, Taku, Uemura, Tsuyoshi, Ishizu, Takehiro, Suzuki, Minoru, Hachinohe, Shingo, Ishiyama, Shintaro, Nonaka, Motohiro, Fukuda, Michiko N, Ohyama, Chikara

“…Background p-Boronophenylalanine (.sup.10BPA) is a powerful .sup.10B drug used in current clinical trials of BNCT. For BNCT to be successful, a high (500…”
Get full text

Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis by Sutoh Yoneyama, Mihoko, Hatakeyama, Shingo, Habuchi, Tomonori, Inoue, Takamitsu, Nakamura, Toshiya, Funyu, Tomihisa, Wiche, Gerhard, Ohyama, Chikara, Tsuboi, Shigeru

“…To investigate the molecular mechanisms of cancer metastasis, we have isolated a high-metastatic bladder cancer cell subpopulation from a low-metastatic cell…”
Get full text

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation by Anan, Go, Yoneyama, Tohru, Noro, Daisuke, Tobisawa, Yuki, Hatakeyama, Shingo, Sutoh Yoneyama, Mihoko, Yamamoto, Hayato, Imai, Atsushi, Iwamura, Hiromichi, Kohada, Yuki, Mikami, Jotaro, Ito, Jun, Kaiho, Yasuhiro, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Sato, Makoto, Ohyama, Chikara

“…Osteopontin (OPN) is a matrix glycoprotein of urinary calculi. This study aims to identify the role of aberrant glycosylation of OPN in urolithiasis. We…”
Get full text

Correction to: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy by Yoneyama, Tohru, Hatakeyama, Shingo, Sutoh Yoneyama, Mihoko, Yoshiya, Taku, Uemura, Tsuyoshi, Ishizu, Takehiro, Suzuki, Minoru, Hachinohe, Shingo, Ishiyama, Shintaro, Nonaka, Motohiro, Fukuda, Michiko N, Ohyama, Chikara

“…An amendment to this paper has been published and can be accessed via the original article…”
Get full text

A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I by Sutoh Yoneyama, Mihoko, Tobisawa, Yuki, Hatakeyama, Shingo, Sato, Misaki, Tone, Kiyoshi, Tatara, Yota, Kakizaki, Ikuko, Funyu, Tomihisa, Fukuda, Minoru, Hoshi, Senji, Ohyama, Chikara, Tsuboi, Shigeru

“…Anti-tumour immunity by cytotoxic T-lymphocytes (CTLs) is essential to suppress tumour progression. Cancer cells that evade CTL immunity proliferate in the…”
Get full text

Renal metastasis of ovarian granulosa cell tumor by Togashi, Kyo, Yoneyama, Tohru, Sutoh Yoneyama, Mihoko, Yamamoto, Hayato, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Futagami, Masayuki, Ohyama, Chikara

“…Introduction We would like to present a rare case of metastatic renal tumor. Case presentation A 60‐year‐old woman presented to our department with a left…”
Get full text

TMEM2 expression is downregulated as bladder cancer invades the muscle layer by Yoneyama, Mihoko Sutoh, Yoneyama, Tohru, Tobisawa, Yuki, Yamamoto, Hayato, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Suzuki, Tadashi, Ohyama, Chikara

“…Cell surface hyaluronidase transmembrane protein 2 (TMEM2), which also serves as a reportedly functions in malignancy of several solid tumors. However, TMEM2…”
Get full text

Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level by Yoneyama, Tohru, Yamamoto, Hayato, Sutoh Yoneyama, Mihoko, Tobisawa, Yuki, Hatakeyama, Shingo, Narita, Takuma, Kodama, Hirotake, Momota, Masaki, Ito, Hiroyuki, Narita, Shintaro, Tsushima, Fumiyasu, Mitsuzuka, Koji, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Duivenvoorden, Wilhelmina, Pinthus, Jehonathan H., Kakeda, Shingo, Ito, Akihiro, Tsuchiya, Norihiko, Habuchi, Tomonori, Ohyama, Chikara

“…Background The presence of glycosylated isoforms of prostate‐specific antigen (PSA) in prostate cancer (PC) cells is a potential marker of their…”
Get full text

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries by Konishi, Sakae, Narita, Takuma, Hatakeyama, Shingo, Yoneyama, Tohru, Yoneyama, Mihoko Sutoh, Tobisawa, Yuki, Noro, Daisuke, Sato, Tendo, Togashi, Kyo, Okamoto, Teppei, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ohyama, Chikara

“…The evaluation of surgical damage is challenging because of the lack of specific biomarkers. Total cell-free DNA (cfDNA) levels have been reported to increase…”
Get full text

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer by Kubota, Yuka, Hatakeyama, Shingo, Yoneyama, Tohru, Yoneyama, Mihoko Sutoh, Hamano, Itsuto, Konishi, Sakae, Okamoto, Teppei, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ohyama, Chikara

“…Purpose To investigate the prognostic significance of total cell-free DNA (cfDNA) level and androgen receptor amplification ( AR -amp) in patients with…”
Get full text

Clinical significance of the Lacdi NA c‐glycosylated prostate‐specific antigen assay for prostate cancer detection by Yoneyama, Tohru, Tobisawa, Yuki, Kaneko, Tomonori, Kaya, Takatoshi, Hatakeyama, Shingo, Mori, Kazuyuki, Sutoh Yoneyama, Mihoko, Okubo, Teppei, Mitsuzuka, Koji, Duivenvoorden, Wilhelmina, Pinthus, Jehonathan H., Hashimoto, Yasuhiro, Ito, Akihiro, Koie, Takuya, Suda, Yoshihiko, Gardiner, Robert A., Ohyama, Chikara

“…To reduce unnecessary prostate biopsies (Pbx), better discrimination is needed. To identify clinically significant prostate cancer ( CSPC ) we determined the…”
Get full text

The role of LIM and SH3 protein-1 in bladder cancer metastasis by Sato, Misaki, Yoneyama, Mihoko Sutoh, Hatakeyama, Shingo, Funyu, Tomihisa, Suzuki, Tadashi, Ohyama, Chikara, Tsuboi, Shigeru

“…The LIM and SH3 protein-1 (LASP-1) is a multi-domain protein that is involved in several malignant cancers. The role of LASP-1 in malignant phenotypes…”
Get full text

In vivo selection of high-metastatic subline of bladder cancer cell and its characterization by Sugiyama, Naoki, Yoneyama, Mihoko Sutoh, Hatakeyama, Shingo, Yamamoto, Hayato, Okamoto, Akiko, Koie, Takuya, Saitoh, Hisao, Yamaya, Kanemitsu, Funyu, Tomihisa, Inoue, Takamitsu, Habuchi, Tomonori, Ohyama, Chikara, Tsuboi, Shigeru

“…The majority of deaths associated with solid tumors are caused by tumor metastasis. To prevent metastasis, it is vital to understand its detailed process. In…”
Get more information

MP06-19 ANTI-TUMOR EFFECT IN BLADDER CANCER MODEL OF TUMOR VASCULATURE-TARGETED 10 B DELIVERY MEDIATED BORON NEUTRON CAPTURE THERAPY by Yoneyama, Tohru, Hatakeyama, Shingo, Yoneyama, Mihoko Sutoh, Yoshiya, Taku, Uemura, Tsuyoshi, Ishizu, Takehiro, Suzuki, Minoru, Hachinohe, Shingo, Ishiyama, Shintaro, Nonaka, Motohiro, Fukuda, Michiko N., Ohyama, Chikara

Get full text

MP07-01 IDENTIFICATION OF ABERRANT GLYCOSYLATION OF OSTEOPONTIN ON URINARY STONE FORMATION by Anan, Go, Yoneyama, Tohru, Noro, Daisuke, Tobisawa, Yuki, Hatakeyama, Shingo, Sutoh Yoneyama, Mihoko, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Sato, Makoto, Ohyama, Chikara

Get full text

MP16-11 HISTOLOGIC AND ENZYMATIC BACKGROUND FOR BIOSYNTHESIS OF ABERRANT GLYCOSYLATED PROSTATE-SPECIFIC ANTIGEN by Yoneyama, Tohru, Tobisawa, Yuki, Ishikawa, Tomokazu, Kaneko, Tomonori, Kaya, Takatoshi, Hatakeyama, Shingo, Yamamoto, Hayato, Yoneyama, Mihoko Sutoh, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ohyama, Chikara

Get full text

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer by Horiguchi, Hirotaka, Hatakeyama, Shingo, Yoneyama, Tohru, Yoneyama, Mihoko Sutoh, Tanaka, Toshikazu, Fujita, Naoki, Okamoto, Teppei, Yamamoto, Hayato, Yoneyama, Takahiro, Yoshizawa, Tadashi, Hashimoto, Yasuhiro, Kawaguchi, Toshiaki, Ohyama, Chikara

“…•The effect of Ki67 index and programmed death-ligand 1 (PD-L1) expression in muscle invasive bladder cancer (MIBC) patients treated with radical cystectomy…”
Get full text

MP45-06 CLINICAL SIGNIFICANCE OF α2,3-SIALYLATED PROSTATE-SPECIFIC ANTIGEN DENSITY AND MRI FOR HIGH-GRADE PROSTATE CANCER IN BIOPSY-NAÏVE MEN WITH ELEVATED PSA LEVEL by Yoneyama, Tohru, Hatakeyama, Shingo, Yoneyama, Mihoko Sutoh, Tobisawa, Yuki, Narita, Takuma, Kodama, Hirotake, Momota, Masaki, Ito, Hiroyuki, Narita, Shintaro, Tsushima, Fumiyasu, Mitsuzuka, Koji, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Duivenvoorden, Wilhelmina, Pinthus, Jehonathan H., Kakeda, Shingo, Ito, Akihiro, Tsuchiya, Norihiko, Habuchi, Tomonori, Ohyama, Chikara

Get full text

PD53-07 CLINICAL SIGNIFICANCE OF THE SIAα2,3GAL-GLYCOSYLATED PROSTATE-SPECIFIC ANTIGEN ASSAY FOR PROSTATE CANCER DETECTION by Yoneyama, Tohru, Tobisawa, Yuki, Ishikawa, Tomokazu, Hatakeyama, Shingo, Mori, Kazuyuki, Yoneyama, Mihoko Sutoh, Okubo, Teppei, Mitsuzuka, Koji, Duivenvoorden, Wilhelmina, Pinthus, Jehonathan H., Hashimoto, Yasuhiro, Ito, Akihiro, Koie, Takuya, Date, Mutsuhiro, Gardiner, Robert A., Ohyama, Chikara

Get full text